Dual-action nanoparticle therapy targets obesity by converting white fat and reducing inflammation

Dual-action nanoparticle therapy targets obesity by converting white fat and reducing inflammation

Scientists at the Terasaki Institute for Biomedical Innovation, in collaboration with the University of Maryland School of Pharmacy, have developed a new nanoparticle therapy that tackles obesity through two complementary mechanisms: converting energy-storing white fat into calorie-burning beige fat while simultaneously reducing obesity-related inflammation.

How sugar loving gut microbiota help fight obesity

Breaking down the microbiology world one bite at a time HomeAbout usMicroBitesThe teamArchivesVolunteeringContactNewsletter How sugar loving gut microbiota help fight obesity Written bySailee Tawade Eating sugar is considered unhealthy, especially when it comes to losing weight. But who doesn’t love eating sugar? Interestingly our cravings for sugar may be influenced by more than just personal preference, since our gut is home to trillions of mi…

Researchers collaborate to develop a dual-action nanotherapy for obesity

Scientists at Terasaki Institute for Biomedical Innovation, in collaboration with the University of Maryland School of Pharmacy, have developed a new nanoparticle therapy that tackles obesity through two complementary mechanisms: converting energy-storing white fat into calorie-burning beige fat while simultaneously reducing obesity-related inflammation.According to the researchers, this innovative approach addresses key limitations of current o…